Jornay Pm Capsule
Product Images NDC 71376-205

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Jornay Pm (NDC 71376-205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ironshore Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Jornay Splimage 20mg V02

JORNAY PM Extended-Release 20 mg oral capsules, with a two-tone color design featuring a light green upper half imprinted with partial 'IRONSHOR' text and a white lower half marked with '20 mg'. Both capsule views are displayed against a measurement scale showing dimensions in millimeters.*

FDA Label Image

Jornay Splimage 40mg V02

Image of a 40 mg capsule of JORNAY PM Extended-Release (Methylphenidate Hydrochloride). The capsule is half teal and half white, with the teal half displaying partial black text likely indicating the labeler Ironshore. The white half is marked with "40 mg" in black text. The capsule size is measured against a millimeter scale.*

FDA Label Image

Jornay Splimage 60mg V02

Capsule dosage form of JORNAY PM Extended-Release, containing 60 mg Methylphenidate Hydrochloride. The capsule is blue on the top half and white on the bottom half, with "60 mg" printed on the white part and partial text visible on the blue part. Manufactured by Ironshore Pharmaceuticals Inc. The image includes a scale in millimeters for size reference.*

FDA Label Image

Jornay Splimage 80mg V02

Image of an 80 mg JORNAY PM Extended-Release capsule, containing Methylphenidate Hydrochloride. The capsule is blue on the top half with partial black text "IRONSHORE" and white on the bottom half displaying "80 mg" in black text. The capsule measures about 21 mm in length.*

FDA Label Image

100mlpills V01

Image of a JORNAY PM Extended-Release capsule of 100 mg strength, marked with '100 mg' on the white lower half and 'IRONSHORE' partially visible on the dark blue upper half. The capsule is an oral dosage form with a smooth, glossy finish, displayed against a gray background with measurement scales.*

FDA Label Image

Structural Formula (Jor00 0012 01)

Chemical structure diagram of Methylphenidate Hydrochloride, the active ingredient in JORNAY PM Extended-Release capsules. The structure features a phenyl ring, ester group, piperidine ring, and hydrochloride component.*

FDA Label Image

Figure (Jor00 0012 02)

A line graph comparing plasma methylphenidate concentration (ng/mL) over time (hours) for JORNAY PM 100 mg and Methylphenidate IR 20 mg capsules. The graph illustrates concentration changes in plasma for two groups (N=11 for JORNAY PM and N=12 for Methylphenidate IR) over a 48-hour period.*

FDA Label Image

Figure (Jor00 0012 03)

A line graph comparing SKAMP-CS scores over time from 8 am to 8 pm for two groups: JORNAY PM (n=64) and placebo (N=53). The y-axis shows SKAMP-CS (LS Mean ± SE) values. The placebo group is represented by a dashed line with open circles, and the JORNAY PM group by a solid line with filled circles, showing differing score trends throughout the day.*

FDA Label Image

Principal Display Panel (Jornay PM® 20 mg Bottle Label)

Label for JORNAY PM Extended-Release Capsules containing 20 mg methylphenidate hydrochloride. The label includes dosage instructions indicating use once daily in the evening, package contains 100 capsules. Manufactured by Patheon Puerto Rico, Inc. and labeled for Ironshore Pharmaceuticals Inc. with storage instructions and dispensing advice for pharmacists.*

FDA Label Image

Principal Display Panel (Jornay PM® 40 mg Bottle Label)

Label for JORNAY PM Extended-Release Capsules containing 40 mg methylphenidate hydrochloride. The label states "Take Only In The Evening" and includes storage instructions and manufacturer information for Ironshore Pharmaceuticals Inc. The package contains 100 capsules.*

FDA Label Image

Principal Display Panel (Jornay PM® 60 mg Bottle Label)

Label for Jornay PM Extended-Release Capsules containing 60 mg methylphenidate hydrochloride. The label specifies the product is for oral use, with the instruction to take only in the evening. It includes storage conditions and manufacturer details, listing Ironshore Pharmaceuticals Inc. as labeler, with packaging by Patheon Puerto Rico, Inc. The package contains 100 capsules.*

FDA Label Image

Principal Display Panel (Jornay PM® 80 mg Bottle Label)

Label for JORNAY PM Extended-Release Capsules, 80 mg methylphenidate hydrochloride. The label includes dosage instructions to take only in the evening, storage instructions, and packaging information. It specifies a 100-capsule count and lists Patheon Puerto Rico as the packager and Ironshore Pharmaceuticals Inc. as the manufacturer.*

FDA Label Image

Principal Display Panel (Jornay PM® 100 mg Bottle Label)

JORNAY PM 100 mg extended-release capsules label showing methylphenidate hydrochloride as the active ingredient. The label includes dosage instructions to take only in the evening and storage conditions. It states the package contains 100 capsules and is manufactured by Ironshore Pharmaceuticals Inc. with packaging by Patheon Puerto Rico, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.